GlassScriptPhysician profile
Amanda L Smith
NPI 1679749014
$1,348.62
in general payments reported to CMS, 2019-2025
17 companies · $565 in 2025
The $565 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $22.82 · 2022: $18.84 · 2023: $389 · 2024: $353 · 2025: $565.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,227 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,226.97 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $312.08 | 2023-2025 | Tymlos |
| Pfizer INC. | $191.66 | 2023-2025 | |
| Amgen INC. | $183.08 | 2022-2025 | Evenity, Prolia |
| Astrazeneca Pharmaceuticals LP | $142.81 | 2025 | Breztri, Farxiga, Airsupra |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $105.24 | 2025 | Caplyta |
| Janssen Biotech, INC. | $90.17 | 2024-2025 | Carvykti, Tremfya |
| Sanofi-Aventis U.S. LLC | $79.99 | 2024 | |
| Paratek Pharmaceuticals, INC. | $55.32 | 2024-2025 | Nuzyra |
| Vertex Pharmaceuticals Incorporated | $34.07 | 2024-2025 | |
| Averitas Pharma INC. | $31.11 | 2024 | Qutenza |
| Pacira Therapeutics, INC. | $22.82 | 2021 | |
| Lilly USA, LLC | $19.38 | 2025 | Zepbound, Mounjaro |
| Novo Nordisk INC | $18.37 | 2025 | Wegovy |
| Astellas Pharma US INC | $17.61 | 2025 | Veozah |
| Exact Sciences Corporation | $17.45 | 2025 | The Cologuard Plus Collection Kit |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.99 | 2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $13.47 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.